ibandronic acid sandoz
sandoz gmbh - ibandronic acid - breast neoplasms; neoplasm metastasis; fractures, bone - drugs for treatment of bone diseases, bisphosphonates - ibandronic acid sandoz is indicated for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.,
ibandronic acid mylan 150mg film-coated tablets
mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - ibandronic acid - film-coated tablet - ibandronic acid 150 mg - drugs for treatment of bone diseases
moderiba ribavirin
abbvie inc. - ribavirin (unii: 49717awg6k) (ribavirin - unii:49717awg6k) - ribavirin 200 mg
moderiba tablet
abbvie corporation - ribavirin - tablet - 200mg - ribavirin 200mg - nucleosides and nucleotides
moderiba tablet
abbvie corporation - ribavirin - tablet - 400mg - ribavirin 400mg - nucleosides and nucleotides
moderiba tablet
abbvie corporation - ribavirin - tablet - 600mg - ribavirin 600mg - nucleosides and nucleotides
ibavyr tablet
pendopharm division of pharmascience inc - ribavirin - tablet - 400mg - ribavirin 400mg - nucleosides and nucleotides
ibavyr tablet
pendopharm division of pharmascience inc - ribavirin - tablet - 600mg - ribavirin 600mg - nucleosides and nucleotides
ibavyr tablet
pendopharm division of pharmascience inc - ribavirin - tablet - 200mg - ribavirin 200mg - nucleosides and nucleotides
eptifibatide strides 0.75 mg/ml solution for infusion
strides arcolab international limited - eptifibatide - solution for infusion - 0.75 mg/ml